Literature DB >> 33971896

Bacterial profile and antimicrobial susceptibility patterns of isolates among patients diagnosed with surgical site infection at a tertiary teaching hospital in Ethiopia: a prospective cohort study.

Gemedo Misha1, Legese Chelkeba2, Tsegaye Melaku3,4.   

Abstract

BACKGROUND: Globally, surgical site infections are the most reported healthcare-associated infection and common surgical complication. In developing countries such as Ethiopia, there is a paucity of published reports on the microbiologic profile and resistance patterns of an isolates.
OBJECTIVE: This study aimed at assessing the bacterial profile and antimicrobial susceptibility patterns of isolates among patients diagnosed with surgical site infection at Jimma Medical Center in Ethiopia.
METHODS: A prospective cohort study was employed among adult patients who underwent either elective or emergency surgical procedures. All the eligible patients were followed for 30 days for the occurrence of surgical site infection (SSI). From those who developed SSI, infected wound specimens were collected and studied bacteriologically.
RESULTS: Of 251 study participants, 126 (50.2%) of them were females. The mean ± SD age of the patients was 38 ± 16.30 years. The overall postoperative surgical site infection rate was 21.1% and of these 71.7% (38/53) were culture positive. On gram stain analysis, 78% of them were Gram-negative, 11.5% were Gram-positive and 10.5% were a mixture of two microbial growths. Escherichia coli accounted for (21.43%), followed by Pseudomonas aeruginosa (19.05%), Proteus species (spp.) 14.29%), Staphylococcus aureus (11.90%), Klebsiella species (11.90%), Citrobacter spp. (9.5%), streptococcal spp. (7.14%), Coagulase-negative S. aureus (CoNS) (2.38%)
CONCLUSION: Gram-negative bacteria were the most dominant isolates from surgical sites in the study area. Among the Gram-negative bacilli, Escherichia coli were the most common bacteria causing surgical site infection. As there is high antibiotic resistance observed in the current study, it is necessary for routine microbial analysis of samples and their antibiogram.

Entities:  

Keywords:  Antimicrobial susceptibility; Bacterial isolates; Ethiopia; Surgical site infection

Year:  2021        PMID: 33971896     DOI: 10.1186/s12941-021-00440-z

Source DB:  PubMed          Journal:  Ann Clin Microbiol Antimicrob        ISSN: 1476-0711            Impact factor:   3.944


  15 in total

1.  Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance.

Authors:  P Astagneau; C Rioux; F Golliot; G Brücker
Journal:  J Hosp Infect       Date:  2001-08       Impact factor: 3.926

2.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections.

Authors:  T C Horan; R P Gaynes; W J Martone; W R Jarvis; T G Emori
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

3.  Significant pathogens isolated from surgical site infections at a community hospital in the Midwest.

Authors:  Carol A Cantlon; Mary E Stemper; William R Schwan; Michael A Hoffman; Salah S Qutaishat
Journal:  Am J Infect Control       Date:  2006-10       Impact factor: 2.918

4.  The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed.

Authors:  R Plowman; N Graves; M A Griffin; J A Roberts; A V Swan; B Cookson; L Taylor
Journal:  J Hosp Infect       Date:  2001-03       Impact factor: 3.926

5.  [Masked carpal tunnel syndrome in diabetic neuropathy].

Authors:  W Hacke
Journal:  Dtsch Med Wochenschr       Date:  1980-06-06       Impact factor: 0.628

6.  Adverse impact of surgical site infections in English hospitals.

Authors:  R Coello; A Charlett; J Wilson; V Ward; A Pearson; P Borriello
Journal:  J Hosp Infect       Date:  2005-06       Impact factor: 3.926

7.  Etiology of surgical site infections after primary total joint arthroplasties.

Authors:  Natividad Benito; María Franco; Pere Coll; María Luz Gálvez; Marcos Jordán; Joaquín López-Contreras; Virginia Pomar; Joan Carles Monllau; Beatriz Mirelis; Mercè Gurguí
Journal:  J Orthop Res       Date:  2014-01-16       Impact factor: 3.494

8.  Reducing surgical site infection incidence through a network: results from the French ISO-RAISIN surveillance system.

Authors:  P Astagneau; F L'Hériteau; F Daniel; P Parneix; A-G Venier; S Malavaud; P Jarno; B Lejeune; A Savey; M-H Metzger; C Bernet; J Fabry; C Rabaud; H Tronel; J-M Thiolet; B Coignard
Journal:  J Hosp Infect       Date:  2009-04-19       Impact factor: 3.926

9.  A multimodal infection control and patient safety intervention to reduce surgical site infections in Africa: a multicentre, before-after, cohort study.

Authors:  Benedetta Allegranzi; Alexander M Aiken; Nejla Zeynep Kubilay; Peter Nthumba; Jack Barasa; Gabriel Okumu; Robert Mugarura; Alexander Elobu; Josephat Jombwe; Mayaba Maimbo; Joseph Musowoya; Angèle Gayet-Ageron; Sean M Berenholtz
Journal:  Lancet Infect Dis       Date:  2018-03-05       Impact factor: 25.071

Review 10.  Highlighting the gaps in quantifying the economic burden of surgical site infections associated with antimicrobial-resistant bacteria.

Authors:  Katia Iskandar; Massimo Sartelli; Marwan Tabbal; Luca Ansaloni; Gian Luca Baiocchi; Fausto Catena; Federico Coccolini; Mainul Haque; Francesco Maria Labricciosa; Ayad Moghabghab; Leonardo Pagani; Pierre Abi Hanna; Christine Roques; Pascale Salameh; Laurent Molinier
Journal:  World J Emerg Surg       Date:  2019-11-21       Impact factor: 5.469

View more
  1 in total

1.  Assessment of Bacterial Profiles and Antimicrobial Susceptibility Pattern of Isolates Among Patients Diagnosed with Surgical Site Infections at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia: A Prospective Observational Cohort Study.

Authors:  Mengistu Abayneh; Molla Asnake; Dassalegn Muleta; Asnake Simieneh
Journal:  Infect Drug Resist       Date:  2022-04-13       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.